Vall d'Hebron Institut de Recerca

Futó vizsgálatok

• Fut, nem toboroz

  A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Study With BI 3720931 (Lenticlair™-ON)

  NCT06962852· 1/2. fázis· Forrás

• Toboroz

  A multicenter, open label, two cohort, single arm, phase II study to evaluate the efficacy and safety of the anti-TROP2 antibody-drug conjugate sacituzumab govitecan in patients with advanced differentiated and anaplastic thyroid neoplasms.

  2023-504898-20-00· 2. fázis· Forrás

• Toboroz

  [18F]PSMA-1007 PET CT in patients with newly-diagnosed prostate cancer

  2023-504026-19-01· 3. fázis· Forrás

• Toboroz

  Clinical trial of trabectedin, irinotecann and low-dose radiation therapy in advanced/metastatic sarcomas.

  NCT05131386· 2. fázis· Forrás

• Fut, nem toboroz

  A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors

  NCT06157892· 2. fázis· Forrás

• Toboroz

  A multicentric, randomized, double-blind, placebo-controlled trial to evaluate the efficacy of COLIRIOBCN070660 administered topically in patients with moderately severe to severe non-proliferative diabetic retinopathy

  2023-505791-30-01· 2/3. fázis· Forrás

• Toboroz

  A PHASE I STUDY OF THE CEACAM5 x CD3 ANTIBODY NILK-2301 IN COLORECTAL CANCER

  2023-508058-24-01· 1. fázis· Forrás

• Fut, nem toboroz

  A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.

  NCT06206837· 1/2. fázis· Forrás

• Toboroz

  A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

  NCT06064877· 3. fázis· Forrás

• Toboroz

  A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

  NCT06136559· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

  NCT06003231· 2. fázis· Forrás

• Toboroz

  Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement

  NCT05727176· 2. fázis· Forrás

• Toboroz

  Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia

  NCT05327894· 3. fázis· Forrás

• Toboroz

  Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

  NCT05363280· 2. fázis· Forrás

• Fut, nem toboroz

  Study of Sonrotoclax (BGB-11417) Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma

  NCT05471843· 1/2. fázis· Forrás

• Toboroz

  ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)

  NCT04916613· 3. fázis· Forrás

• Fut, nem toboroz

  Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCC

  NCT05301842· 3. fázis· Forrás

• Fut, nem toboroz

  A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors

  NCT05135559· 3. fázis· Forrás

• Fut, nem toboroz

  Lorlatinib Continuation Study

  NCT05144997· 4. fázis· Forrás

• Fut, nem toboroz

  A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

  NCT04895696· 2. fázis· Forrás

• Fut, nem toboroz

  BIOMIGA: Results From Magnetic Resonance Imaging

  NCT06633484· Forrás

• Toboroz

  An international trial for children with atypical teratoid/rhabdoid tumours (ATRT)

  2022-501456-28-00· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer

  NCT03873402· 3. fázis· Forrás

• Fut, nem toboroz

  Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib

  NCT03235245· 2. fázis· Forrás

• Fut, nem toboroz

  A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma

  NCT03470922· 2/3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok3 toboroz
• Prosztatarák2 toboroz
• Akut limfoid leukémia (ALL)1 toboroz
• Diabéteszes retinopátia1 toboroz
• Fej-nyaki daganatok1 toboroz
• Hemofília1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Pajzsmirigyrák1 toboroz
• Szarkóma1 toboroz
• Vastagbélrák1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  Optimizing Albuminuria Treatment in CKD With Finerenone and Semaglutide

  NCT07819227· 2. fázis· Forrás

• Lezárult

  A study to test how well BI 3720931 is tolerated and whether it improves lung function in people with cystic fibrosis (LenticlairTM 1)

  2023-503281-23-00· 1/2. fázis· Forrás

• Lezárult

  NXP800 in subjects with Ovarian Cancer

  NCT05226507· 1. fázis· Forrás

• Lezárult

  RANDOMIZED, CONTROLLED, OPEN, MULTICENTRIC CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A COMBINATION OF ANTI-TUBERCULOUS DRUGS BASED ON HIGH DOSE RIFAMPICIN, HIGH DOSE MOXIFLOXACIN AND LINEZOLID IN PATIENTS WITH BACILLIFEROUS PULMONARY TUBERCULOSIS (RML-TB).

  2023-509075-17-00· 2. fázis· Forrás

• Lezárult

  Study of BMS-986466 with Adagrasib with or without Cetuximab in Participants with KRAS G12C-mutant Solid Tumors

  NCT06024174· 1/2. fázis· Forrás

• Lezárult

  A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related Epilepsy (TrustTSC OLE)

  NCT05604170· 3. fázis· Forrás

• Lezárult

  A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

  NCT06065540· 3. fázis· Forrás

• Lezárult

  A Phase 2 Study of the Effects of Ponsegromab on Health-Related Quality of Life and Safety in Patients With Heart Failure (GARDEN-TIMI 74)

  NCT05492500· 2. fázis· Forrás

• Lezárult

  A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Assess the Efficacy, Safety, Tolerability, PK, and Biomarker Effects of PTC857 in Adult Subjects With Amyotrophic Lateral Sclerosis (CARDINALS)

  NCT05349721· 2. fázis· Forrás

• Lezárult

  Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer

  NCT05673811· 2. fázis· Forrás

• Lezárult

  Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder

  NCT05512377· 2. fázis· Forrás

• Fut, nem toboroz

  Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations

  NCT05544552· 1/2. fázis· Forrás

• Lezárult

  Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight

  NCT04306315· 4. fázis· Forrás

• Lezárult

  Phase II trial of Pembrolizumab and Olaparib in homologous-recombination deficient (HRD) advanced colorectal cancer (CRC).

  NCT05201612· 2. fázis· Forrás

• Lezárult

  An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers

  2023-508954-25-00· 1/2. fázis· Forrás

• Fut, nem toboroz

  New Clinical End-points in patients with primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients

  NCT05113004· 2. fázis· Forrás

• Lezárult

  A Study to Evaluate Safety, Pharmacokinetics, and Preliminary Clinical Activity of RO7276389 Alone and in Combination with Cobimetinib in Participants with BRAF-V600 Mutation-Positive Advanced Solid Tumor or BRAF-V600 Mutation-Positive Melanoma with Central Nervous System Metastases

  2023-506310-43-00· 1. fázis· Forrás

• Lezárult

  Adjuvant Immunotherapy with Nivolumab + Relatlimab Fixed-dose Combination versus Nivolumab Monotherapy after Complete Resection of Stage III-IV Melanoma

  NCT05002569· 3. fázis· Forrás

• Lezárult

  Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)

  NCT05016882· 2. fázis· Forrás

• Lezárult

  Pembrolizumab Plus Lenvatinib in Combination with Belzutifan in Solid Tumors

  2023-503905-12-00· 2. fázis· Forrás

• Lezárult

  Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  NCT04658472· 2. fázis· Forrás

• Lezárult

  Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61)

  NCT04704219· 2. fázis· Forrás

• Lezárult

  An open-label Phase 1 study of NEO-PTC-01 in patients with advanced or metastatic melanoma

  NCT04625205· 1. fázis· Forrás

• Lezárult

  Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients

  NCT04300790· 2. fázis· Forrás

• Lezárult

  ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19

  NCT06831799· Forrás

• Fut, nem toboroz

  A Multi-Center Expanded Access Program (EAP) for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors with Rearranged During Transfection (RET) Activation (LIBRETTO-201)

  NCT03906331· 4. fázis· Forrás

• Fut, nem toboroz

  Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients

  NCT03814746· 3. fázis· Forrás

• Lezárult

  The Late Presenter Treatment Optimisation Study

  NCT03696160· 3. fázis· Forrás

• Lezárult

  Risk Factors and Outcomes of Ischemic Stroke Associated With Tandem or Isolated Cervical Artery Occlusion in Anterior and Posterior Circulation

  NCT06965036· Forrás

• Lezárult

  A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

  NCT03141177· 3. fázis· Forrás

• Lezárult

  A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion

  NCT02398656· 3. fázis· Forrás

• Lezárult

  Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)

  NCT02231749· 3. fázis· Forrás

• Lezárult

  An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors

  NCT01968109· 1/2. fázis· Forrás

Vizsgálati helyszínek

• Vall D'hebron Institut De Recerca54 vizsgálat
• Vall d'Hebron Institute of Research5 vizsgálat

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Migrén44 munka · 1 vizsgálat
• Sclerosis multiplex (SM)34 munka · 0 vizsgálat
• Neuroblasztóma11 munka · 0 vizsgálat
• Sarlósejtes vérszegénység9 munka · 2 vizsgálat